Thank you, Madam Chair.
I'd like to agree with Chris wholeheartedly. I think this issue around technetium supply in many ways has shown the value of nuclear medicine to our patients now, but more importantly, it is enabling us to redefine how we will practise in the future. I think, amidst dealing with the crisis, we have to recognize that this is an opportunity to redefine our practice.